SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-594443
Filing Date
2016-05-18
Accepted
2016-05-18 16:06:02
Documents
3
Period of Report
2016-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d192295d8k.htm 8-K 15194
2 EX-99.1 d192295dex991.htm EX-99.1 13380
3 GRAPHIC g192295g59i87.gif GRAPHIC 4374
  Complete submission text file 0001193125-16-594443.txt   35492
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 161660541
SIC: 2836 Biological Products, (No Diagnostic Substances)